Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica

International Journal of Epidemiology

Volumn 29, Issue 1, 2000, Pages 180-188

  Coen, P G ^a,b   Cartwright, K ^c   Stuart, J ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Asymptomatic carriage; Immunity; Mathematical models; Meningococcal disease

Indexed keywords

MENINGOCOCCUS VACCINE;

DISEASE PREVALENCE; INFECTIOUS DISEASE; MEDICAL GEOGRAPHY; METHODOLOGY;

ARTICLE; HUMAN; IMMUNIZATION; INCIDENCE; MATHEMATICAL MODEL; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; PREVALENCE; PRIORITY JOURNAL;

EID: 0033998703     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/29.1.180     Document Type: Article

References (48)

1. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986;18:25-34.
2. Coen PG, Heath PT, Barbour ML, Garnett GP. Mathematical models of Haemophilus influenzae type b. Epidemiol Infect 1998;120:281-95.
3. Dowling JN, Sheehe PR, Feldman HA. Pharyngeal pneumococcal acquisition in 'normal' families: a longitudinal study. J Infect Dis 1971; 124:9-17.
4. Gray BM, Converse GM, Dillon HCJ. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
5. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families. Antibody correlates of infection and symptomatology. J Infect Dis 1990;161:480-86.
6. Aycock WL, Mueller JH. Meningococcus carrier rates and meningitis incidence. Bact Rev 1950;14:115-60.
7. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978;137:112-21.
8. De Wals P. Longitudinal Study of Asymptomatic Meningococcal Carriage in Two Populations of Schoolchildren. These de Doctorat en Santé Publique. Bruxelles: Université Catholique de Louvain, 1983.
9. Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997;7: R49-54.
10. Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99:591-601.
11. Pether JVS, Lightfoot NF, Scott RJD, Morgan J, Steelperkins A, Sheard SCS. Carriage of Neisseria meningitidis - investigations in a military-establishment. Epidemiol Infect 1988;101:21-42.
12. Griffiss JM, Brandt BL, Jarvis GA. Natural immunity to Neisseria meningitidis. In: Vedros NA (ed.). Evolution of Meningococcal Disease. Boca Raton, Florida: CRC Press Inc., 1987, pp.99-119.
13. Anderson RM, May RM. Infectious Diseases of Humans. Oxford: Oxford University Press, 1991.
14. De Wals P, Gilquin C, De Maeyer S et al. Longitudinal study of asymptomatic meningococcal carriage in two Belgian populations of schoolchildren. J Infect 1983;6:147-56.
15. Blakebrough IS, Greenwood BM, Whittle HC, Bradley AK, Gilles HM. The epidemiology of infections due to Neisseria meningitids and Neisseria lactamica in a Northern Nigerian community. J Infect Dis 1982; 146:626-37.
16. World Development Report. Investing in Health. Oxford University Press: World Bank, 1993.
17. Jones DM. Epidemiology of meningococcal disease in Europe and the USA. In: Cartwright K (ed.). Meningococcal Disease. Chichester, UK: John Wiley, 1995, pp. 147-57.
18. Pinner RW, Gellin BG, Bibb WF et al. Meningococcal disease in the United States - 1986. J Infect Dis 1986;164:368-74.
19. Jones DM, Mallard RH. Age incidence of meningococcal inection England and Wales, 1984-1991. J Infect 1993;27:83-88.
20. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969;129:1327-48.
21. Edwards EA, Devine LF, Sengbusch CH, Ward HW. Immunological investigations of meningococcal disease. Scand J Infect Dis 1977;9: 105-10.
22. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in Fortran. The Art of Scientific Computing. Cambridge: Cambridge University Press, 1994.
23. Crawley MJ. GLIM for Ecologists. Oxford: Blackwell Scientific, 1993.
24. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. Am J Epidemiol 1993;137:1022-34.
25. Farrington CP. Modelling forces of infection for measles, mumps and rubella. Stat Med 1990;9:953-67.
26. Grenfell BT, Anderson RM. The estimtion of age-related rates of infection from case notifications and serological data. J Hyg. Camb 1985;95:419-36.
27. Scholten RJPM, Bijlmer HA, Poolman JT et al. Meningococcal disease in the Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis 1993;16:237-46.
28. Cartwright KAV, Stuart JM, Noah ND. An outbreak of meningococcal disease in Gloucestershire. Lancet 1986;i:558-61.
29. Caugant DA, Froholm LO, Bovre K et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci 1986;83:4927-31.
30. Hubert B, Watier L, Garnerin P, Richardson S. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 1992;166:542-45.
31. Caugant DA, Hoiby EA, Magnus P et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994;32:323-30.
32. Maiden MCJ, Feavers IM. Population genetics and global epidemiology of the human pathogen Neisseria meningitidis. In: Baumberg S, Young JPW, Saunders JR, Wellington EMH (eds). Population Genetics of Bacteria. Cambridge: Cambridge University Press, 1995, pp.269-93.
33. Hassan-King MKA, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect 1988;16:55-59.
34. Rake G. Studies of meningococcus infection. VI. The carrier problem. J Exp Med 1934;59:553-76.
35. De Wals P, Bouckaert A. Methods in estimating the duration of bacterial carriage. Int J Epidemiol 1985;14:628-54.
36. Greenfield S, Sheehe PR, Feldman HA. Meningococcal carriage in a population of 'Normal' families. J Infect Dis 1971;123:67-73.
37. Feavers IM, Fox AJ, Gray S, Jones DM, Maiden MC. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 1996;3:444-50.
38. Kim JJ, Mandrell RE, Griffiss JM. Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes. Infect Immun 1989;57: 602-08.
39. Ward MJ, Lambden PR, Heckels JE. Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins of pathogenic and non-pathogenic Neisseria species. FEMS Microbiol Lett 1992;94:283-90.
40. Suker J, Feavers IM, Achtman M, Morelli G, Wang JF, Maiden MCJ. The porA gene in serogroup A meningococci - evolutionary stability and mechanism of genetic variation. Mol Microbiol 1994;12:253-65.
41. Olsen SF, Djurhmus K, Rasmussen HD, Larssen SO, Zoffman H, Lind I. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 1991;106:445-57.
42. Griffiss JM, Yamasaki R, Eastbrook M, Kim JJ. Meningococcal molecular mimicry and the search for an ideal vaccine. Trans Roy Soc Trop Med Hyg 1991;85:32-36.
43. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129:1307-26.
44. Kaiser AB, Hennekens CH, Saslaw MS, Hayes PS, Bennett JW. Seroepidemiology and chemoprophylaxis to disease due to sulphonamide-resistant Neisseria meningitidis in a civilian population. J Infect Dis 1974; 130:217-24.
45. Achtman M. Global Epidemiology of Meningococcal Disease. Chichester, UK: John Wiley, 1995.
46. MMWR. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:1-10.
47. Barbour ML, Mayon White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995;171:93-98.
48. Takala AK, Santosham M, Almeido-Hill J et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12: 593-99.